Bergua Burgués, Juan Miguel | Hematología y Hemoterapia |

Resultados: 231
Tipo Título / Nombre Autor(es) Año
Incidence, risk factors and outcomes od second neoplasm in patients with acute promyelocytic leukemia: the PETHEMA -PALG experience Sobas M, Knopinska-Posluszny W, Bergua Burgues JM, Rodríguez-Veiga R, Cano Ferri I..., Montesinos P 2023
Update results of VEN-A-QUI study: a phase 1-2 trial to assess the safety and efficacy of triplets for newly diagnosed unfit AML patients: Azacitidine or low-dose Cytarabline with Venetoclax and Quizartinib Bergua Burgués JM, Rodríguez-Veiga R, Cano Ferri I..., Montesinos P 2023
Preliminary results of QUIWI: a double blinded, randomized clinical trial comparing standard chemotherapy plus quizartinib versus placebo in adult patients with newly diagnosed FLT3-ITD wild- type AML Montesinos P, Rodríquez-Veiga R, Bergua Burgues JM, Algarra L..., Labrador J 2023
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO Martín García-Sancho A, Baile M, Dlouhy I, Sancho JM..., Bergua J 2023
Safety and efficacy of tafasitamab ± lenalidomide added to first-line R?CHOP for DLBCL: Phase 1b First-MIND study Belada D, Kopeckova K, Bergua Burgués JM, Stevens D, André M, Pérez Persona E, Pichler P, Staber PB, Trn?ný M, Duell J, Waldron-Lynch M, Wagner S, Mukhopadhyay A, Dirnberger-Hertweck M, Burke JM, Nowakowski GS 2023
Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry Bernal T, Fernández Moreno A, LaIglesia A de, Benavente C..., Bergua Burgués JM 2023
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group Sargas C, Ayala R, Larráyoz MJ, Chillón MC, Rodriguez-Arboli E..., Bergua J, PETHEMA cooperative study group 2023
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia Simoes C, Villar S, Ariceta B, Garcés JJ, Burgos L..., Bergua JM 2023
Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets González Barca E, Tomás-Roca L, Esteve A, Rodríguez M, Gato L..., Bergua Burgués JM 2023
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry Sargas C, Ayala R, Larráyoz MJ, Chillón MC..., Bergua JM 2023